APA (7th ed.) Citation

T, K., A, G., SC, H., AL, M., J, S., M, H., . . . A, K. (2024). Hydrochlorothiazide and increased risk of atypical fibroxanthoma and pleomorphic dermal sarcoma. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 22(4), 513. https://doi.org/10.1111/ddg.15379

Chicago Style (17th ed.) Citation

T, Kuntz, Grimm A, Hofmann SC, Michalowitz AL, Schaller J, Hellmich M, Assaf C, Oellig F, and Kreuter A. "Hydrochlorothiazide and Increased Risk of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma." Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 22, no. 4 (2024): 513. https://doi.org/10.1111/ddg.15379.

MLA (9th ed.) Citation

T, Kuntz, et al. "Hydrochlorothiazide and Increased Risk of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma." Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, vol. 22, no. 4, 2024, p. 513, https://doi.org/10.1111/ddg.15379.